![Nataliya Agafonova](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nataliya Agafonova
Chief Tech/Sci/R&D Officer at
LONGEVERON INC.
Net worth: 185 013 $ as of 30/09/2026
Profile
Dr. Nataliya Agafonova is a Chief Medical Officer at Longeveron, Inc. Dr. Agafonova was previously employed as a Senior Medical Director by Bristol Myers Squibb Co. and a Senior Medical Director by Otsuka Pharmaceutical Development & Commercialization, Inc. She received her doctorate degree from Bogomolets National Medical University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/10/2026 | 68,778 ( 2.26% ) | 185 013 $ | 30/09/2026 |
Nataliya Agafonova active positions
| Companies | Position | Start |
|---|---|---|
| LONGEVERON INC. | Chief Tech/Sci/R&D Officer | 01/07/2023 |
Former positions of Nataliya Agafonova
| Companies | Position | End |
|---|---|---|
Otsuka Pharmaceutical Development & Commercialization, Inc.
 Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Chief Tech/Sci/R&D Officer | 01/06/2023 |
| BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | - |
Education of Nataliya Agafonova
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
29
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
Bogomolets National Medical University
 Bogomolets National Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Longeveron, Inc.
 Longeveron, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops cellular therapies for aging-related and life-threatening conditions | Health Technology |
- Stock Market
- Insiders
- Nataliya Agafonova
